Catalyst Brief

← Calendar

Readoutin 165d

Sun Pharmaceutical Industries, Inc. — CTP-543

Phase 3 primary completion: Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata.

Date
May 2027
Type
Readout
Indication
Alopecia Areata

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.